Before you sell to, join or invest in Embold Therapeutics, Inc.
MentionFox check on Embold Therapeutics, Inc.: only 2 sources on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/embold-therapeutics-inc-form-d-26000002
Check Embold Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Embold Therapeutics, Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Embold Therapeutics, Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-02-09.
Embold Therapeutics, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on February 9, 2026. The filing reports $2.47M sold. Its industry group is Biotechnology. It names Gjalt Huisman (Executive Officer, Director) (SEC Form D/A, February 9, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Embold Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-02-09 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Embold Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Embold Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in February 2026, largest first.
Get an email when Embold Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Embold Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Embold Therapeutics, Inc. →Get the full cited report on Embold Therapeutics, Inc.
What the filing shows about Embold Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Embold Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Embold Therapeutics, Inc.'s address as 2682 Eaton Ave, Redwood City, CA 94062.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Embold Therapeutics, Inc. →
Amended on 2026-07-24: the offering size changed from $3,000,000 to $4,975,000; the amount sold changed from $130,000 to $2,470,587; the number of investors changed from 2 to 7. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Embold Therapeutics, Inc. See pricing
Embold Therapeutics, Inc. is a registered filer with the SEC (CIK 2109643) and has filed since 2026-02-09. 3 filings are on record, the latest on 2026-07-24.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Embold Therapeutics, Inc.'s Form D of 2026-02-09 names Gjalt Huisman as its officers, directors or promoters.
Its new offerings report $630K sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 765 filings in Biotechnology, totalled by week. The dot is this raise, $2.47M, on the same scale — one filing against the whole group's total, so it sits low by construction.
The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes.
Gjalt Huisman is named as Executive Officer and Director on the Form D that Embold Therapeutics, Inc. filed with the SEC on 9 February 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-02-09 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Embold Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Embold Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Embold Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Embold Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Embold Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Embold Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/embold-therapeutics-inc-form-d-26000002